DMP 504 is a high molecular weight polymer currently under development by T
he DuPont Merck Pharmaceutical Company as a novel bile acid sequestrant to
lower serum cholesterol. To assess its safety, DMP 504 is incorporated into
rodent diet for oral administration to rats and mice. An analytical method
was developed to determine the accuracy and homogeneity of the blends. Sin
ce a physical separation or extraction of DMP 504 from the diet was not fea
sible, near-infrared spectroscopy (near-IR) was employed. The near-IR metho
d provides accurate and precise results for blends containing 1.5-8.0% of D
MP 504. Comparison of results at the 1.5% level with a cholate binding refe
ree method is also presented. Both methods provided equivalent results for
the 1.5% level. (C) 1999 Elsevier Science B.V. All rights reserved.